Search

everythinglearnresearchcommunity

for

Search:↓

The monkey's hair loss was due to an autoimmune disease, not genetics.

Atopic dermatitis increases the risk of some autoimmune diseases.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Testosterone may slow down wound healing and increase inflammation.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.